H.R. 9877

Health Equity and Accountability Act of 2026

Sponsor: Raul Ruiz

26 cosponsors
Follow this bill

Official summary

No official summary yet.

Text of the bill

Expand all

I Data collection and reporting

II Culturally and linguistically appropriate health and health care

III Health workforce diversity

A Diversifying the health care workplace

B Substance Use Disorder Treatment and Behavioral and Mental Health Workforce

C ACCESS in Mental Health Act

D Developing the Community Health Workforce Act

IV Improving Health Care Access and Quality

A Reducing Barriers to Accessing Care

B Improvement of Coverage

C Expansion of Access

1 General Provisions

2 Rural

3 Indian Communities

4 Providers

5 Dental

D Advancing Health Equity Through Payment and Delivery Reform

E Health Empowerment Zones

F Equitable Health Care for All

G Investing in Equity

H Miscellaneous

I Territories Health Equity

1 Medicare

A Part A

B Part B

C Medicare Advantage (Part C)

D Part D

2 Miscellaneous

V Improving health outcomes for women, gender-diverse people, children, and families

A Underserved communities

B Pregnancy screening

C Pregnancy-Related care

D Federal agency coordination on maternal health

E Reproductive and Sexual Health

F Children’s Health

G Elder Care

H Miscellaneous provisions

VI Mental health and substance use disorders

A Access to care and funding streams

B Interprofessional care

C Workforce development

D Children’s mental health

E Community-Based care

F Reports

G Miscellaneous provisions

VII Addressing high-impact minority diseases

A Cancer

B Viral hepatitis and liver cancer control and prevention

C Acquired bone marrow failure diseases

D Cardiovascular disease, chronic disease, obesity, and other disease issues

E HIV/AIDS

F Diabetes

G Lung disease

H Tuberculosis

I Osteoarthritis and Musculoskeletal Diseases

J Sleep and circadian rhythm disorders

K Kidney disease research, surveillance, prevention, and treatment

L Diversity in clinical trials

M Additional provisions addressing high-impact minority diseases

Sec. 7901C–7. Stomach Cancer Prevention and Early Detection Act

(a) NCI review on current state of stomach cancer incidence, prevention, screening, awareness, and future public health importance

(1) Review. The Director of the National Cancer Institute shall conduct a review of—

(A) the current incidence of stomach cancer in the United States;

(B) the risk factors for stomach cancer, including the incidence of such risk factors among high-risk populations and the general public;

(C) the optimal age range to test for and treat Helicobacter pylori (H. pylori) infection, as a risk factor, for the purpose of primary prevention in high-risk populations and the general population;

(D) the availability and frequency of screening for stomach cancer, including utilization and effectiveness, among high-risk populations;

(E) the availability and effectiveness of endoscopic screenings in high-risk populations;

(F) the availability and effectiveness of endoscopic resection and surveillance endoscopy for patients with confirmed gastric intestinal metaplasia (GIM) with high-grade dysplasia and early gastric cancer;

(G) the benefits of surveillance endoscopy for patients at elevated risk, including patients with gastric intestinal metaplasia (GIM) who are at increased risk of gastric cancer due to ethnic background, family history, or other risk stratification parameters such as smoking and H. pylori infection;

(H) current awareness and education about stomach cancer risk factors, prevention, symptoms, screening, and treatment options among high-risk populations and the general public; and

(I) current Federal efforts to increase awareness and education of stomach cancer among high-risk populations and the general public.

(2) Report. Not later than 18 months after the date of enactment of this Act, the Director of the National Cancer Institute shall—

(A) submit to the Congress a report on the results of the review under paragraph (1); and

(B) include in such report recommendations for—

(i) establishing a clear definition of high-risk populations in the United States;

(ii) informing researchers, clinicians, physicians, patients, and other relevant stakeholders on—

(I) identifying high-risk individuals; and

(II) effective methods for detecting precancerous lesions and early gastric cancer;

(iii) establishing routine screening guidelines for stomach cancer; and

(iv) actions to improve research on, prevention and early diagnosis of, and screening and treatment for stomach cancer.

(b) Department of Defense study on stomach cancer incidence and risk factors among military personnel

(1) Study. The Secretary of Defense, in coordination with the Director of the National Cancer Institute and the Director of the Centers for Disease Control and Prevention, shall conduct a study on the incidence, risk factors, prevention, and early detection of stomach cancer among members of the Armed Forces and former members of the Armed Forces.

(2) Elements. The study under paragraph (1) shall include—

(A) an examination of—

(i) the incidence, prevalence, and mortality rates of stomach cancer among members of the Armed Forces serving on active duty and former members of the Armed Forces who served on active duty;

(ii) the identification of service-related or deployment-related risk factors, including exposure to burn pits, hazardous chemicals, contaminated water, occupational hazards, and endemic infections such as Helicobacter pylori (H. pylori);

(iii) disparities in stomach cancer outcomes based on race, ethnicity, gender, Armed Force, or geographic deployment history within military populations;

(iv) the availability and use of stomach cancer screening, diagnostic, and treatment services within the military health system and the health system of the Department of Veterans Affairs; and

(v) opportunities to improve prevention and early detection strategies within the military health system and the health system of the Department of Veterans Affairs; and

(B) relevant coordination with the Surveillance, Epidemiology, and End Results Program and other national cancer registries to ensure comprehensive data collection and analysis.

(3) Report. Not later than 18 months after the date of the enactment of this Act, the Secretary of Defense shall submit to Congress a report on the findings of the study under paragraph (1), including—

(A) policy and programmatic recommendations to reduce stomach cancer incidence and mortality among members of the Armed Forces and former members of the Armed Forces; and

(B) proposed strategies for integrating stomach cancer awareness, screening, and treatment protocols into the military health system and the health system of the Department of Veterans Affairs.

N Health Equity and Rare Disease Act

O Asunción Valdivia Heat Illness, Injury, and Fatality Prevention

P New Era of Preventing End-Stage Kidney Disease

VIII Health Information Technology

A Reducing Health Disparities Through Health IT

B Modifications To Achieve Parity in Existing Programs

C Additional Research and Studies

D Closing Gaps in Funding To Adopt Certified EHRs

E Expanding Access to Telehealth Services

IX Accountability and Evaluation

X Addressing Social Determinants and Improving Environmental Justice

A In General

B Gun Violence

C Nutrition for women, children, families

1 Senior hunger prevention

2 Closing the meal gap

D Universal school meals

1 School breakfast program

2 School lunch program

3 Elementary and secondary education data

4 Amendments to other programs and laws

XI Protections to combat regulatory harm to health equity